Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

E. S. Albright,Renee A. Desmond,D. Bell
DOI: https://doi.org/10.2337/DIACARE.27.2.632
2004-02-01
Diabetes Care
Abstract:The efficacy of glycemic control in type 1 diabetic patients with either once- or twice-daily glargine insulin injection was evaluated in this long-term, prospective, nonrandomized study. Eighty-two type 1 diabetic patients were followed over 12–15 months after conversion from a single bedtime NPH insulin injection to a single bedtime insulin glargine injection. These patients were switched with the availability of glargine insulin to reduce frequency and severity of nocturnal hypoglycemia and to improve fasting glucose levels. This group of type 1 diabetic patients was switched to glargine insulin in place of twice-daily NPH. These patients continued their same bolus therapy with either insulin lispro or aspart and underwent frequent (three to five times daily) home glucose monitoring. This study showed the expected fewer nocturnal hypoglycemic events, but the primary outcome was an improvement in glycemic control based on the HbA1c values. …
What problem does this paper attempt to address?